article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

Cannabis Advocacy With a Digital Twist. Much like RoC, patient advocacy is at the forefront of Veriheal’s work, which includes connecting patients with medical marijuana (MMJ) doctors, collecting patient data to improve future treatment, and battling harmful cannabis stigmas with education.

article thumbnail

Is Weed Legal in Japan? Cannabis Legalization Bill Explained

Veriheal

The revised legislation would permit clinical use and production of cannabis for medical CBD products, like Epidiolex , that have been approved in the U.S. and Europe to treat severe epilepsy, as well as other medical conditions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

South African Research Team Says Cannabis is ‘Very Promising’ as an Opioid Replacement

Veriheal

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. Grinspoon’s devotion to cannabis stems from his father Lester Grinspoon’s longtime advocacy efforts. .

article thumbnail

Legislation To Produce And Research Cannabis Introduced

NORML

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. .

article thumbnail

Peter Reynolds Article: The Desperate Rearguard Action the British Medical Establishment is Fighting Against Cannabis

Cannabis Law Report

I have a particular interest in epidemiology and clinical trials and in particular running clinical trials in childhood epilepsy.”. But I point you to his final sentence and his declared adherence to the doctrine and close involvement in the multi-million pound industry of clinical trials.

article thumbnail

MAPS: “California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction”

Cannabis Law Report

SB 519 has served as a successful trial balloon for a state’s psychedelic drug policy, and we’ll take the lessons we’ve learned from this session as we look to gain more support for what was a popular and evidence-based piece of legislation. Policy and Advocacy Director, MAPS . Ismail Lourido Ali, J.D.

article thumbnail

NIDA Monopoly is Over: New DEA-Registered Cannabis Growers Can Supply Researchers with Product

Cannabis Law Report

Use the plants for their own studies and/or FDA clinical trials. People are investing resources in legislation and advocacy efforts designed to fix a problem that doesn’t exist. And that’s not all. Please help spread the word: The NIDA Monopoly is over.

DEA 52